Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2311206
Max Phase: Preclinical
Molecular Formula: C26H33N5O13P2
Molecular Weight: 685.52
Molecule Type: Small molecule
Associated Items:
ID: ALA2311206
Max Phase: Preclinical
Molecular Formula: C26H33N5O13P2
Molecular Weight: 685.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1c(C)c2c(c(O)c1C/C=C(\C)COP(=O)(O)CP(=O)(O)OC[C@@H]1O[C@H](n3cnc4c(N)ncnc43)[C@@H](O)[C@H]1O)C(=O)OC2
Standard InChI: InChI=1S/C26H33N5O13P2/c1-12(4-5-14-19(32)17-15(7-41-26(17)35)13(2)22(14)40-3)6-42-45(36,37)11-46(38,39)43-8-16-20(33)21(34)25(44-16)31-10-30-18-23(27)28-9-29-24(18)31/h4,9-10,16,20-21,25,32-34H,5-8,11H2,1-3H3,(H,36,37)(H,38,39)(H2,27,28,29)/b12-4+/t16-,20-,21-,25-/m0/s1
Standard InChI Key: MCYWJNDIVYMDSF-XDKQCGSTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 685.52 | Molecular Weight (Monoisotopic): 685.1550 | AlogP: 1.27 | #Rotatable Bonds: 12 |
Polar Surface Area: 268.13 | Molecular Species: ACID | HBA: 16 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.03 | CX Basic pKa: 4.92 | CX LogP: -2.35 | CX LogD: -4.55 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.09 | Np Likeness Score: 1.37 |
1. Pankiewicz KW, Lesiak-Watanabe KB, Watanabe KA, Patterson SE, Jayaram HN, Yalowitz JA, Miller MD, Seidman M, Majumdar A, Prehna G, Goldstein BM.. (2002) Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia., 45 (3): [PMID:11806722] [10.1021/jm0104116] |
2. Rejman D, Olesiak M, Chen L, Patterson SE, Wilson D, Jayaram HN, Hedstrom L, Pankiewicz KW.. (2006) Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase., 49 (16): [PMID:16884314] [10.1021/jm060479r] |
Source(1):